Home      About this journal      Authors      Referees      Editors      Readers      Archive      Contact us
Effects on SuxiaoJiuxin pills in the treatment of qi stagnation and blood stasis type patients with acute coronary syndromes undergoing early percutaneous coronary intervention
Hits 1430  Download times 1435  Received:February 26, 2019  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1673-9043.2019.04.11
Key Words   acute coronary syndrome;qi stagnation and blood stasis type;coronary revascularization;SuxiaoJiuxin pills
Author NameAffiliationE-mail
ZHENG Wang Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China  
WEI Yihong Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China  
LI Guanghao Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China shanxianlhg@sina.com 
LIU Yu Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China  
SHEN Lin Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China  
DENG Bing Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China  
TANG Nuo Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 200032, China  
Abstract
    [Objective] To observe the effect of SuxiaoJiuxin pills on qi stagnation and blood stasis type patients with ACS coronary revascularization.[Methods] By the method of random, double blindness and placebo control, we enrolled 58 ACS patients with qi stagnation and blood stasis. They were randomly divided into control group and treatment group, 29 cases in each group. On the basic western medicine treatment, control group received placebo and treatment group received Suxiaojiuxin pills. After 6 month intervention, agiogram were test to value the effect of Suxiaojiuxin pills.[Results] After 6 month treatment, angina pectoris symptom scores, TCM symptom scores and LVEF were all ameliorated in both the control and treatment group (P<0.01), and more significant in latter group. The in-stent restenosis occurred in 1 case in control group, but none in treatment group, in the coronary re-angiogram after treatment. Safety index were negative in both group.[Conclusions] The combination of SuxiaoJiuxin pills could significantly improve qi stagnation and blood stasis symptoms of ACS patients and improve the left ventricular systolic function, without obvious side effect.

You are the 1626728 visitor.

Copyright @ 2007
Address:   Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.